Organ procurement organizations are challenging a federal rule that they say unfairly measures their performance and threatens widespread disruption across the transplant and donation system.
Issued by the HHS’ Centers for Medicare & Medicaid Services, the 2020 rule “imposes draconian penalties” on organ procurement groups that rank low in transplant and donation rates based on metrics “substantially influenced by factors beyond” their control, the groups said in their Friday lawsuit, which aims to have the rule vacated.
Brought by LifeLink Foundation Inc., Iowa Donor Network, and other groups in the US District Court for the Middle District of Florida, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
